Colony Group LLC Novo Nordisk A S Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Colony Group LLC holds 35,781 shares of NVO stock, worth $1.73 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

35,781

Previous 18,083 97.87%

Holding current value

$1.73 Million

Previous $2.93 Million 11.21%

% of portfolio

0.05%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $1.61 Million - $3.53 Million	17,698 Added 97.87%	35,781 $3.25 Million
Q2 2023 Aug 15, 2023	SELL	$155.98 - $172.65 $14,506 - $16,056	-93 Reduced 0.51%	18,083 $2.93 Million
Q1 2023 May 16, 2023	SELL	$132.34 - $159.14 $386,829 - $465,166	-2,923 Reduced 13.85%	18,176 $2.89 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $564,947 - $745,532	5,509 Added 35.34%	21,099 $2.86 Million
Q3 2022 Nov 15, 2022	BUY	$95.28 - $116.93 $425,425 - $522,092	4,465 Added 40.13%	15,590 $1.55 Million

Q2 2022 Aug 16, 2022	BUY	$103.24 - $121.81 $305,590 - $360,557	2,960 Added 36.25%	11,125 $1.24 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $60,235 - $72,813	647 Added 8.61%	8,165 $907,000
Q4 2021 Feb 15, 2022	SELL	$95.88 - $117.08 $126,753 - $154,779	-1,322 Reduced 14.95%	7,518 $842,000
Q3 2021 Nov 17, 2021	BUY	$84.42 - $106.62 $206,153 - $260,366	2,442 Added 38.17%	8,840 $849,000
Q2 2021 Aug 18, 2021	SELL	$67.66 - $84.76 $5,615 - $7,035	-83 Reduced 1.28%	6,398 $536,000
Q1 2021 May 21, 2021	BUY	$67.06 - $75.82 $75,107 - $84,918	1,120 Added 20.89%	6,481 $437,000
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $37,375 - $43,173	-585 Reduced 9.84%	5,361 $374,000
Q3 2020 Nov 17, 2020	BUY	$63.69 - $70.22 $69,804 - $76,961	1,096 Added 22.6%	5,946 $413,000
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $61,759 - $71,676	-1,055 Reduced 17.87%	4,850 $318,000
Q1 2020 May 18, 2020	BUY	$49.46 - $64.78 $97,930 - $128,264	1,980 Added 50.45%	5,905 $355,000
Q4 2019 Feb 18, 2020	BUY	$49.86 - $58.26 $195,700 - $228,670	3,925 New	3,925 $227,000
Q3 2019 Nov 26, 2019	SELL	$47.54 - $53.43 $198,859 - $223,497	-4,183 Closed	0 $0
Q2 2019 Aug 19, 2019	BUY	$46.79 - $52.47 $195,722 - $219,482	4,183 New	4,183 $214,000

Others Institutions Holding NVO

# of Institutions

1,684

Shares Held

304M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account